Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The cancer diagnostics market was valued at USD 61.50 billion in 2023. It is expected to grow at a CAGR of 13.6% during the forecast period of 2024-2032 and attain a market value of USD 194.54 billion in 2032. The market value is impacted by the increasing use of such platforms and ongoing technological advancements in this field. There has been a significant increase in number of patent applications associated with cancer diagnostics, driven by increasing global incidence of cancer requires advanced diagnostic tools for early detection and treatment planning.
The global cancer diagnostics patent landscape report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for global cancer diagnostics include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within cancer diagnostic technologies.
Flow cytometry, a powerful technique used in cancer diagnosis to analyze the physical and chemical properties of cells or particles. Using fluorescently labeled antibodies, it can identify and quantify specific cell populations, detect abnormal cell markers, and assess cell health, which is critical for diagnosing hematologic cancers such as leukemia and lymphoma. This method provides fast, accurate and detailed information about cancer cells, which helps in effective diagnosis and treatment. Therefore, such technical innovations are impacting the patent landscape significantly.
Cancer diagnostics refers to tools, materials, and equipment used in medical laboratories and clinical settings to detect, analyze, and monitor cancer. These include a wide range of products such as reagents, analysis kits, testing equipment, imaging systems (such as MRI and CT scanners), molecular diagnostic tools (such as PCR machines) and specialty equipment (such as flow cytometers and digital pathology scanners). These consumables and instruments are essential for performing various tests, analyzes and imaging studies to diagnose cancer, determine its stage, guide treatment decisions, and monitor the effectiveness of treatment and the progression of the disease over time.
Cancer diagnostics continues to evolve, driven by the growing healthcare expenditure, especially in developing economies, and supports the adoption of advanced diagnostic technologies. Large investments in research and development activities by pharmaceutical and biotechnology companies are leading to the development of new and better diagnostic products. Cooperation between diagnostic companies and research institutes enabling the development and marketing of innovative diagnostic tools, which is a driving factor to boost market value in the forecast period.
Increasing Technological Innovation in Cancer Diagnosis is Expected to Augment the Market Growth
Technological innovations in cancer diagnosis include advances such as next-generation sequencing (NGS), digital pathology and the integration of artificial intelligence. These innovations increase the accuracy and efficiency of cancer detection, enable personalized treatment strategies and facilitate real-time monitoring of disease progression, improving patient outcomes and fueling market growth.
For instance, In June 2022, F. Hoffmann-La Roche Ltd announced the launch of its BenchMark ULTRA PLUS System (including hardware, software and assays) which is an advanced tissue staining platform. The system enables fast and accurate test results so that doctors can make timely decisions about the patient's treatment for cancer.
Rising Demand for Personalized Medicine is Expected to Propel the Cancer Diagnostics Industry Growth
The growing demand for personalized medicine in cancer care is driving the introduction of advanced diagnostic instruments and accessories. These tools enable comprehensive genomic profiling and molecular diagnostics to help oncologists tailor treatment to individual patient characteristics, improving treatment efficacy and patient outcomes and accelerating market expansion.
The report provides an in-depth analysis of the patents in this field by the following segmentation -
Breakup by Product
Breakup by Technology
The breakup based on technology includes positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), multi-parameter flow cytometry, immunohistochemistry, microarray and next generation sequencing (NGS). Cancer diagnostic investigations have been conducted with the chosen patent families labelled based on the technologies to which they pertain.
Positron emission tomography (PET) is an advanced imaging technique used in cancer diagnosis to visualize and evaluate the metabolic activity of tissues. PET scans contain small amounts of a radioactive tracer that accumulates in areas of high metabolic activity, such as tumors. By identifying these areas, PET scans can help diagnose cancer, determine its stage, assess response to therapy and monitor disease recurrence. This non-invasive imaging plays a vital role in oncology, providing detailed information about the biological behaviour of tumours, aiding treatment planning and improving patient care.
Detailed technological data will be provided for all specified segments classified in this report.
The United States is one of the leading jurisdictions for cancer diagnostics patents, having around 310,000 patents. The presence of a well-established healthcare infrastructure, a robust legal framework and prominent research institutions engaged in innovations contributes to the patent landscape significantly.
Holding a substantial portion of the global population, China is another vital jurisdiction and is witnessing rapid growth in patent filings. The expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications. Innovations like development of novel contrast agents and imaging probes is amongst major growth factors.
Among the players with Cancer Diagnostics patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
Often referred to as Roche, this multinational healthcare corporation with its headquarters located in Basel, Switzerland focuses on pharmaceuticals and diagnostics. Leading the way in cancer diagnostics, Roche provides cutting-edge methods for early and precise cancer detection, including liquid and tissue biopsies and sophisticated molecular testing. The company's broad portfolio and dedication to personalized medicine greatly improve patient outcomes and cancer treatment.
A major global healthcare company specializing in diagnostics, medical devices, nutrition and generics. In can...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include GE HealthCare Technologies, Inc., Qiagen N.V., and Becton Dickinson & Company among others.
The global cancer diagnostics patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:
Global Ovarian Cancer Diagnostics and Therapeutics Market
Global Companion Diagnostics Market
Global Diagnostic Imaging Services Market
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
Scope of the Report | Details |
Analysis by Product |
|
Key Players Mentioned |
|
Geographies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share